Baoling Liu Selected Research

Histone Deacetylase Inhibitors

1/2021	Modulation of Brain Transcriptome by Combined Histone Deacetylase Inhibition and Plasma Treatment Following Traumatic Brain Injury and Hemorrhagic Shock.
1/2019	Comparative analysis of isoform-specific and non-selective histone deacetylase inhibitors in attenuating the intestinal damage after hemorrhagic shock.
1/2018	Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model.
1/2018	Histone Deacetylase Inhibition Attenuates Cardiomyocyte Hypoxia-Reoxygenation Injury.
6/2015	Hypothermia and valproic acid activate prosurvival pathways after hemorrhage.
4/2015	Protective effect of suberoylanilide hydroxamic acid against lipopolysaccharide-induced liver damage in rodents.
2/2015	Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.
12/2014	Effect of pharmacologic resuscitation on the brain gene expression profiles in a swine model of traumatic brain injury and hemorrhage.
8/2014	Development of a novel neuroprotective strategy: combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells.
8/2014	Citrullinated histone H3: a novel target for the treatment of sepsis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Baoling Liu Research Topics

Disease

35	Hemorrhagic Shock 01/2021 - 06/2007
28	Shock 01/2022 - 03/2008
28	Hemorrhage 01/2022 - 06/2007
16	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2022 - 12/2012
12	Hypoxia (Hypoxemia) 10/2021 - 04/2008
12	Sepsis (Septicemia) 05/2021 - 08/2014
10	Inflammation (Inflammations) 11/2022 - 08/2010
10	Wounds and Injuries (Trauma) 10/2021 - 04/2008
10	Septic Shock (Toxic Shock Syndrome) 02/2021 - 11/2009
6	Infections 02/2021 - 08/2014
6	Acute Lung Injury 08/2018 - 02/2012
5	Hypothermia 06/2015 - 04/2008
4	Multiple Trauma (Multiple Injuries) 11/2019 - 12/2013
3	Neoplasms (Cancer) 10/2020 - 01/2005
3	Endotoxemia 08/2020 - 08/2013
3	Atrophy 11/2016 - 08/2014
3	Brain Edema (Cerebral Edema) 09/2014 - 12/2012
2	Pneumonia (Pneumonitis) 01/2021 - 07/2012
2	Ischemia 01/2018 - 02/2012
2	Body Weight (Weight, Body) 07/2015 - 04/2015
2	Brain Injuries (Brain Injury) 12/2013 - 12/2012
1	Stroke (Strokes) 01/2022
1	Hypotension (Low Blood Pressure) 01/2021
1	Carcinogenesis 01/2021
1	Glioma (Gliomas) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Osteoporosis 05/2019
1	Lymphatic Metastasis 04/2019
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Amyloidosis 12/2016

Drug/Important Bio-Agent (IBA)

30	Histone Deacetylase InhibitorsIBA 01/2021 - 06/2007
26	Valproic Acid (Depakote)FDA LinkGeneric 10/2021 - 03/2008
15	Histones (Histone)IBA 05/2021 - 06/2007
14	LipopolysaccharidesIBA 05/2021 - 08/2008
14	Saline SolutionIBA 01/2021 - 02/2008
13	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 06/2007
13	salicylhydroxamic acid (SHAM)IBA 02/2016 - 06/2007
12	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2005
12	Vorinostat FDA Link 04/2015 - 11/2009
8	Protein-Arginine DeiminasesIBA 05/2021 - 08/2014
8	CytokinesIBA 11/2016 - 01/2005
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2010
6	Histone Deacetylase 6IBA 01/2019 - 07/2015
5	Ringer's LactateIBA 01/2022 - 06/2007
5	EnzymesIBA 05/2021 - 08/2010
5	Caspase 3 (Caspase-3)IBA 01/2019 - 07/2009
5	tubastatin AIBA 12/2018 - 07/2015
5	SolutionsIBA 04/2015 - 04/2008
4	Lactic Acid (Lactate)FDA LinkGeneric 12/2013 - 08/2009
3	CalciumIBA 10/2021 - 01/2019
3	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 05/2021 - 08/2014
3	ACY1083IBA 01/2019 - 01/2018
3	TubulinIBA 01/2019 - 01/2016
3	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 12/2014 - 02/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2021 - 12/2016
2	Neuroprotective AgentsIBA 01/2021 - 08/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 02/2012
2	Messenger RNA (mRNA)IBA 01/2021 - 08/2012
2	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2018
2	CyclodextrinsIBA 01/2019 - 01/2018
2	MC1568IBA 01/2019 - 01/2018
2	YW3-56IBA 08/2018 - 02/2016
2	SteroidsIBA 12/2016 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 07/2015
2	Claudin-3IBA 01/2016 - 03/2010
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 07/2015 - 04/2015
2	Sodium Chloride FDA LinkGeneric 04/2015 - 12/2012
2	serum P-component (CIt)IBA 08/2014 - 09/2011
2	Hematoxylin (Haematoxylon)IBA 02/2014 - 04/2013
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2014 - 04/2013
2	Pyruvic Acid (Pyruvate)IBA 12/2013 - 06/2007
2	Peroxidase (Myeloperoxidase)IBA 12/2012 - 07/2012
2	Phosphotransferases (Kinase)IBA 07/2012 - 09/2010
2	Blood Proteins (Serum Proteins)IBA 09/2011 - 03/2010
2	beta CateninIBA 08/2009 - 07/2009
2	KetonesIBA 02/2008 - 06/2007
1	IonsIBA 10/2021
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 04/2019
1	Estrogens (Estrogen)FDA Link 04/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	Glial Fibrillary Acidic ProteinIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	CollagenIBA 09/2017
1	Arachidonic Acid (Vitamin F)IBA 09/2017
1	Adenosine Diphosphate (ADP)IBA 09/2017

Therapy/Procedure

27	Resuscitation 01/2022 - 06/2007
7	Punctures 12/2018 - 08/2013
7	Ligation 12/2018 - 08/2013
4	Therapeutics 01/2022 - 03/2010
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 05/2010 - 04/2008
2	Catheters 01/2018 - 04/2008
2	Induced Hypothermia 06/2015 - 08/2014
1	Intravenous Administration 11/2022
1	Ovariectomy (Oophorectomy) 05/2019
1	Intravenous Injections 01/2019
1	Vascular Surgical Procedures 01/2018
1	Elective Surgical Procedures 01/2018